Alloy Tirzepatide Review: Cost, the Weight Care Fee & Honest Verdict (2026)

Alloy's compounded tirzepatide is $199 a month, and every medication price sits on top of a mandatory $99/month Weight Care fee — so the real floor is about $298 a month, not $199. What you get for it is the broadest GLP-1 formulary in this category: brand Wegovy and Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide and liraglutide, from a menopause-focused practice.

What Alloy is

Alloy is a menopause-focused telehealth brand, whose consulting doctors are all certified by The Menopause Society — a real, specific, and rare credential in this category. Its Weight Care program runs the broadest GLP-1 formulary this review has found: brand Wegovy, brand Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide, and liraglutide.

The mandatory fee that changes the real minimum price

Alloy's compounded tirzepatide is at $199/month, and compounded semaglutide from as low as $70/month — but a mandatory $99/month Alloy Weight Care fee sits on top of every medication price. That means the true minimum for even the cheapest compounded option is roughly $169/month, not the $70 headline the lowest tier might suggest at first glance. Read every Alloy price as "medication cost plus $99," not as a standalone figure.

The brand-vs-compounded question

Alloy offers both routes: brand Wegovy and Zepbound (FDA-approved) alongside compounded semaglutide, tirzepatide, and liraglutide — genuinely the broadest menu in this category. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials, while brand Zepbound is. See our Zepbound cost and savings guide for the branded benchmark.

How the care model holds up

Alloy's real strengths: the broadest GLP-1 formulary in this category, all consulting doctors certified by The Menopause Society — a rare, specific, and checkable credential — and a genuine price range spanning compounded to brand-name options from one platform. The trade-offs: it's menopause-focused, best suited for women in menopause or perimenopause rather than men or younger patients; the mandatory $99/month Weight Care fee sits on top of every medication price, meaningfully raising the real minimum cost; and compounded semaglutide isn't available in seven states/DC (AL, AR, CA, NV, LA, MS, DC). As with any GLP-1 program, calculate medication cost plus the $99 fee together before comparing Alloy's price against a flat-rate competitor; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Alloy's menopause-specific credentialing and broad formulary are genuine, real positives for the audience it's built for — but remember to add the mandatory $99/month Weight Care fee to every medication price before comparing it to a flat-rate competitor. If you want a genuinely all-in flat price with no separate fee layered on top, compare it against CoreAge Rx or Sunlight. See our best tirzepatide providers ranking for the full field.